Sanford Health   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Sioux Falls SD United States (1894)

Organization Overview

First Clinical Trial
2007
NCT00286234
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Patrick Kelly | Sanford Health | Sanford Health/Sanford Clinic ENT | Sanford Heart Center | Sanford Orthopedics and Sports Medicine | Sanford Orthopedics & Sports Medicine - Sioux Falls, SD | Sanford Research/USD | Sanford Vascular Associates

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ankle Injuries (Phase 2)

Atrial Fibrillation (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Carpal Tunnel Syndrome (Phase 4)

Critical Illness (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Embolism (Phase 3)

Hypertriglyceridemia (Phase 4)

Infections (Phase 3)

Insulin Resistance (Phase 4)

Knee Injuries (Phase 4)

Laryngeal Neoplasms (Phase 1)

Metabolic Syndrome (Phase 4)

Mouth Neoplasms (Phase 1)

Oropharyngeal Neoplasms (Phase 1)

Pain, Postoperative (Phase 4)

Papilloma (Phase 2)

Papillomavirus Infections (Phase 2)

Premature Birth (Phase 2)

Respiratory Tract Infections (Phase 2)

Rotator Cuff Injuries (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Surgical Wound Infection (Phase 4)

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 23
  • # of Trial APIs: 37